Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice

References

• Akerfeldt S, Geijer S, Holubars E, Fuchs G, Brundin M (1972). Prophylactic and therapeutic antiviral effect of human gamma globulin. Biochem Pharmacol 21: 503–509.
   Google Scholar
• Akerfeldt S, Lofberg E, Fuchs G (1973). Antiviral effect of human gamma globulin in mice. Comparison be-tween the efficacy of local and systemic administration. Biochem Pharmacol 22: 2911–2917.
   Google Scholar
• Beland JL, Sobel RA, Adler H, Del-pan NC, Rimm IJ (1999). B cell-deficient mice have increased suscep-tibility to HSV-1 encephalomyelitis and mortality. J Neuroimmunol 94: 122–126.
   Google Scholar
• Birmanns B, Reibstein I, Steiner I (1993). Characteriza-tion of an in vivo reactivation model of herpes simplex from mouse trigeminal ganglia. I Gen Virol 74: 2487–2491.
   Google Scholar
• Corey L, Spear PG (1986). Infection with herpes simplex virus. N Eng J. Med 314: 686–691.
   PubMed Web of Science ®Google Scholar
• Davis WB, Taylor J, Oakes JE (1979). Ocular infection with herpes simplex virus type 1: prevention of acute her-petic encephalitis by systemic administration of virus-specific antibody. I Infect Dis 140: 534–540.
   PubMed Web of Science ®Google Scholar
• Erlich KS, Dix RD, Mills J (1987). Prevention and treat-ment of experimental herpes simplex virus encephali-tis with human immune serum globulin. Antimicrob Agents Chem other 31: 1006–1009.
   Google Scholar
• Erlich KS, Mills J (1986). Passive immunotherapy for en-cephalitis caused by herpes simplex virus. Rev Infect Dis 8: S439–S445.
   Google Scholar
• Laycock KA, Lee SF, Brady RH, Pepose JS (1991). Charac-terization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest Opthalmol Vis Sci 32(10): 2741–2746.
   Google Scholar
• LeBlanc RA, Pesnicak L, Godleski M, Straus SE (1999). Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation. Virology 262: 230–236.
   Google Scholar
• Lekstrom-Himes JA, Pesnicak L, Straus SE (1998). The quantity of latent viral DNA load correlates with the rel-ative rates at which herpes simplex virus type 1 and 2 cause recurrent genital herpes outbreaks. I Virol 71: 2760–2764.
   Google Scholar
• Levine B, Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE (1991). Antibody-mediated clearance of alphavirus infection from neurons. Science 254: 856–860.
   PubMed Web of Science ®Google Scholar
• Maggioncalda J, Mehta A, Su YH, Fraser NW, Block TM (1996). Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology 225: 72–81.
   PubMed Web of Science ®Google Scholar
• Martin JR, Jenkins FJ, Henken DB (1991). Targets of herpes simplex virus type 1 infection in a mouse model. Acta Neuropathol (Berl) 82: 353–363.
   Google Scholar
• McKendall RR, Klassen T, Baringer JR (1979). Host de-fences in herpes simplex infections of the nervous sys-tem: effect of antibody on disease and viral spread. Infect Immun 23: 305–311.
   PubMed Web of Science ®Google Scholar
• Mester JC, Glorioso JC, Rouse BT (1991). Protection against zosteriform spread of herpes simplex virus by mono-clonal antibodies. I Infect Dis 163: 263–269.
   Google Scholar
• Oakes JE, Rosemond-Hornbeak H (1978). Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infect Immun 21: 489–495.
   PubMed Web of Science ®Google Scholar
• Sanna PP, De Logu A, Williamson RA, Hom YL, Straus SE, Bloom FE (1996). Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV. Virology 215: 101–106.
   PubMedGoogle Scholar
• Sawtell N (1998). The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. I Virol 72: 6888–6892.
   PubMed Web of Science ®Google Scholar
• Sawtell NM, Poon D, Tansky CS, Thompson RL (1998). The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and corre-lates with reactivation. I Virol 72: 5343–5350.
   PubMed Web of Science ®Google Scholar
• Simmons A, Nash A (1985). Role of antibody in primary and recurrent herpes simplex virus infection. I Virol 53: 944–948.
   PubMed Web of Science ®Google Scholar
• Whitley RJ (2001). Herpes simplex viruses. In: Fields Virology. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, (eds). Lippincott, Williams & Wilkins Publishers: Philadelphia, pp 2461–2509.
   Google Scholar